Skip to main content
OpenTrials
Completed

NCT Number: NCT01716390

Lipid-lowering Effect of Plant Stanol Drink

To determine the effect of investigational products on serum LDL cholesterol.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Good Food Practice

Uppsala, Sweden

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy mildly to moderate hypercholesterolemic (serum total cholesterol 5.2-8.5 mmol/l) adults
  • signed written informed consent

Exclusion criteria

  • participation in a clinical study within 30 days prior to screening visit and throughout the study
  • severe obesity
  • consumption of lipid/cholesterol lowering medication 1 month prior to the screening visit and throughout the study
  • consumption of plant stanol or plant sterol containing food products such as Benecol or Becel pro active 1 month prior to visit 2

Treatment and study plan

Drink that contains plant stanols

Dietary Supplement

Placebo drink

Dietary Supplement

Primary outcomes

  1. Change in serum LDL cholesterol

    Time frame: 0 vs 4 weeks

Sponsors and collaborators

Lead sponsor

Raisio Group

Industry

Registry information

Official study title

The Effect of Plant Stanol Drink on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol Concentrations

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Oct 29, 2012
Registry last updated
Oct 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.